About Fdas
Fdas is a company based in Nottingham (United Kingdom) founded in 2004 was acquired by Tentamus in April 2016. Fdas has raised $464.1 thousand across 2 funding rounds from investors including Tentamus, E-Synergy and Catapult Ventures. The company has 20 employees as of December 31, 2017. Fdas offers products and services including Microbiology Testing, Chemistry Testing, Stability Studies, and Consulting Services. Fdas operates in a competitive market with competitors including BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.
- Headquarter Nottingham, United Kingdom
- Employees 20 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tentamus Pharma (Uk) Limited
- Date of Incorporation 04 Feb, 2004
- Jurisdiction DERBY, DERBYSHIRE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
$2.13 M (USD)540as on Dec 31, 2021
-
EBITDA
Not available
-
Total Equity Funding
$464.1 K (USD)
in 2 rounds
-
Latest Funding Round
$103.25 K (USD), Grant
Nov 14, 2007
-
Investors
Tentamus
& 2 more
-
Employee Count
20
as on Dec 31, 2017
-
Acquired by
Tentamus
(Apr 06, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fdas
Fdas offers a comprehensive portfolio of products and services, including Microbiology Testing, Chemistry Testing, Stability Studies, and Consulting Services.
Testing for microbial contaminants in pharmaceuticals and devices.
Analysis of substances and impurities in pharmaceutical products.
Evaluation of pharmaceutical shelf-life and degradation.
Guidance on GMP compliance and method validation.
Funding Insights of Fdas
Fdas has successfully raised a total of $464.1K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $103.25 thousand completed in November 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fdas
Fdas has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Tentamus, E-Synergy and Catapult Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Investment solutions are provided by Catapult Ventures for growth.
|
Locked | Locked | Locked | |
|
Analytical and quality assurance services are provided for diverse industries.
|
Locked | Locked | Locked |
Investor details for Fdas
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fdas
Investment portfolio details for Fdas
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fdas
Detailed financials for Fdas
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fdas Comparisons
Peer comparison for Fdas
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fdas
Fdas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Integrated R&D services are provided for pharmaceuticals and allied sectors.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
Detailed competitors of Fdas
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fdas
Complete news archive for Fdas
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fdas
Fdas was founded in 2004.
Fdas is headquartered in Nottingham, United Kingdom.
Fdas is a funded company, having raised a total of $464.1K across 2 funding rounds to date.
As of Dec 31, 2017, the latest employee count at Fdas is 20.
FDAS was founded in 2004 and is based in Nottingham, United Kingdom. Operations focus on the pharmaceutical testing sector, with MHRA-accredited laboratories delivering GMP analytical services. Expertise includes ICH stability storage, method development, and validation. Key services encompass raw material testing, stability testing, product release testing, development support, and microbiology analysis. MHRA accreditation was retained in 2014.
Fdas's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
Fdas offers Microbiology Testing, Chemistry Testing, Stability Studies, and Consulting Services.
Fdas has 3 investors. Key investors include Tentamus, E-Synergy, and Catapult Ventures.